For research use only. Not for therapeutic Use.
A metformin derivative exerting a potent anti-tumor effect; HL010183 inhibits proliferation and invasion of Hs578T triple-negative (TN) breast cancer cells; 100 fold more potent than metformin.
KEYWORDS: HL 010183 | supplier | Antitumor agent | HL010183 | HL-010183 | CAS [1429218-03-0] | [1125365-14-1] | Glucose | Homeostasis | AMPK | metformin | anti-tumor | proliferation | Hs578T | breast cancer
Catalog Number | I047590 |
CAS Number | 1429218-03-0 |
Molecular Formula | C14H20N6.HCl |
Purity | ≥95% |
IUPAC Name | 2-N,2-N-dimethyl-4-N-(2-propylphenyl)-1,3,5-triazine-2,4,6-triamine;hydrochloride |
InChI | InChI=1S/C14H20N6.ClH/c1-4-7-10-8-5-6-9-11(10)16-13-17-12(15)18-14(19-13)20(2)3;/h5-6,8-9H,4,7H2,1-3H3,(H3,15,16,17,18,19);1H |
SMILES | CCCC1=CC=CC=C1NC2=NC(=NC(=N2)N)N(C)C.Cl |
Reference | M Koh et al. A novel metformin derivative, HL010183, inhibits proliferation and invasion of triple-negative breast cancer cells. Bioorg. Med. Chem. 2013, 21(8), 2305-2313. |